AUG 06, 2016 5:11 PM PDT

Deciphering the Transformation of B Cells Into Memory Cells

WRITTEN BY: Kara Marker
Thanks to the memory capabilities of our immune cells, our body knows how to fight pathogens better the second, third, and fourth times we encounter them. Immune memory also makes vaccination possible. So how exactly do immune cells transition into being memory cells?
medicalxpress.com
A new study from Osaka University in collaboration with the RIKEN Center for Integrative Medical Sciences and the Immunology Frontier Research Center, researchers sought to confirm the mechanism behind the induction of B cells in the germinal center into differentiated memory B cells. 

B cells are infamous for running the block with T cells during the cell-mediated immune response, also known as the adaptive immune response. B cells are charged with making antibodies which recognize pathogen antigens and further the process of targeting and killing these foreigners. During a pathogenic invasion, lymphocytes like B and T cells and continuously being produced to go out and do their job. Some B cells are tasked with making antibodies, and some stay behind to become memory B cells, responsible for reminding the immune system when the same pathogen enters the body later in life.

A home base type of structure called the germinal center is produced within secondary lymph nodes when either a vaccine or a virus enters the body. This is where the memory B cells are induced to differentiate from germinal-center B cells, scientists know, but what signal exists to facilitate this transition? 

Researchers previously thought that memory B cells were induced to differentiate by high-affinity germinal B cells. However, researchers from the current study, published in Nature Immunology, found that it was quite the opposite. It was the germinal center B cells with the lowest affinity maturation for antigens that were most likely to be induced to differentiate into memory B cells. 

The researchers also found high expression of a transcription factor called Bach2 in the germinal cell B cells with low antigen affinity, indicating that Bach2 is important for memory B cell differentiation. This finding also appears to be key for future vaccine experiments based on targeting memory B cells to improve immune memory. 
 


Sources: PubMed Health, Osaka University 
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 02, 2020
Immunology
APR 02, 2020
Transforming T Cells into Powerful Memory Cells That Target Cancer
New cancer treatments are now based on harnessing the power of the human body’s own immune cells to get the job do ...
APR 09, 2020
Drug Discovery & Development
APR 09, 2020
Does Hydroxychloroquine Really Work Against COVID-19?
Although US President Donald Trump is a strong supporter of antimalarial drug Hydroxychloroquine as a treatment for COVI ...
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
Loading Comments...